{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T06:25:40Z","timestamp":1791008740615,"version":"4.1.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,12,12]],"date-time":"2010-12-12T00:00:00Z","timestamp":1292112000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s10585-010-9363-7","type":"journal-article","created":{"date-parts":[[2010,12,11]],"date-time":"2010-12-11T05:43:46Z","timestamp":1292046226000},"page":"113-125","source":"Crossref","is-referenced-by-count":63,"title":["Versican induces a pro-metastatic ovarian cancer cell behavior which can be inhibited by small hyaluronan oligosaccharides"],"prefix":"10.1007","volume":"28","author":[{"given":"Miranda P.","family":"Ween","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Hummitzsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond J.","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin K.","family":"Oehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Ricciardelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,12,12]]},"reference":[{"key":"9363_CR1","unstructured":"Stewart BW (2003) WHO world cancer report. Lyon, France"},{"issue":"4","key":"9363_CR2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","volume":"59","author":"A Jemal","year":"2009","unstructured":"Jemal A, Siegel R, Ward E et al (2009) Cancer statistics, 2009. CA Cancer J Clin 59(4):225\u2013249","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"9363_CR3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1525-1438.2006.00273.x","volume":"16","author":"T Doig","year":"2006","unstructured":"Doig T, Monaghan H (2006) Sampling the omentum in ovarian neoplasia: when one block is enough. Int J Gynecol Cancer 16(1):36\u201340","journal-title":"Int J Gynecol Cancer"},{"issue":"6835","key":"9363_CR4","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/35077241","volume":"411","author":"LA Liotta","year":"2001","unstructured":"Liotta LA, Kohn EC (2001) The microenvironment of the tumour-host interface. Nature 411(6835):375\u2013379","journal-title":"Nature"},{"issue":"3\u20134","key":"9363_CR5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.biochi.2004.10.025","volume":"87","author":"P Zigrino","year":"2005","unstructured":"Zigrino P, Loffek S, Mauch C (2005) Tumor-stroma interactions: their role in the control of tumor cell invasion. Biochimie 87(3\u20134):321\u2013328","journal-title":"Biochimie"},{"issue":"4","key":"9363_CR6","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1055\/s-2006-948556","volume":"24","author":"C Ricciardelli","year":"2006","unstructured":"Ricciardelli C, Rodgers RJ (2006) Extracellular matrix of ovarian tumors. Semin Reprod Med 24(4):270\u2013282","journal-title":"Semin Reprod Med"},{"issue":"2","key":"9363_CR7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0304-3835(95)03743-G","volume":"91","author":"MJ Gardner","year":"1995","unstructured":"Gardner MJ, Jones LM, Catterall JB et al (1995) Expression of cell adhesion molecules on ovarian tumour cell lines and mesothelial cells, in relation to ovarian cancer metastasis. Cancer Lett 91(2):229\u2013234","journal-title":"Cancer Lett"},{"issue":"4","key":"9363_CR8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF00123391","volume":"14","author":"MJ Gardner","year":"1996","unstructured":"Gardner MJ, Catterall JB, Jones LM et al (1996) Human ovarian tumour cells can bind hyaluronic acid via membrane CD44: a possible step in peritoneal metastasis. Clin Exp Metastasis 14(4):325\u2013334","journal-title":"Clin Exp Metastasis"},{"issue":"5\u20136","key":"9363_CR9","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/sj.bjc.6690410","volume":"80","author":"KE Wilson","year":"1999","unstructured":"Wilson KE, Bartlett JM, Miller EP et al (1999) Regulation and function of the extracellular matrix protein tenascin-C in ovarian cancer cell lines. Br J Cancer 80(5\u20136):685\u2013692","journal-title":"Br J Cancer"},{"issue":"3","key":"9363_CR10","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1006\/gyno.1999.5388","volume":"73","author":"T Strobel","year":"1999","unstructured":"Strobel T, Cannistra SA (1999) Beta1-integrins partly mediate binding of ovarian cancer cells to peritoneal mesothelium in vitro. Gynecol Oncol 73(3):362\u2013367","journal-title":"Gynecol Oncol"},{"issue":"1","key":"9363_CR11","first-page":"150","volume":"60","author":"MA Anttila","year":"2000","unstructured":"Anttila MA, Tammi RH, Tammi MI et al (2000) High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer. Cancer Res 60(1):150\u2013155","journal-title":"Cancer Res"},{"issue":"3","key":"9363_CR12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/ijc.11423","volume":"107","author":"K Voutilainen","year":"2003","unstructured":"Voutilainen K, Anttila M, Sillanpaa S et al (2003) Versican in epithelial ovarian cancer: relation to hyaluronan, clinicopathologic factors and prognosis. Int J Cancer 107(3):359\u2013364","journal-title":"Int J Cancer"},{"issue":"1","key":"9363_CR13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1479-5876-2-23","volume":"2","author":"RS Freedman","year":"2004","unstructured":"Freedman RS, Deavers M, Liu J et al (2004) Peritoneal inflammation\u2013\u2013a microenvironment for epithelial ovarian cancer (EOC). J Transl Med 2(1):23","journal-title":"J Transl Med"},{"issue":"2","key":"9363_CR14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.pgp.0000229994.02815.f9","volume":"26","author":"R Salani","year":"2007","unstructured":"Salani R, Neuberger I, Kurman RJ et al (2007) Expression of extracellular matrix proteins in ovarian serous tumors. Int J Gynecol Pathol 26(2):141\u2013146","journal-title":"Int J Gynecol Pathol"},{"issue":"4","key":"9363_CR15","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1172\/JCI33775","volume":"118","author":"HA Kenny","year":"2008","unstructured":"Kenny HA, Kaur S, Coussens LM et al (2008) The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin. J Clin Invest 118(4):1367\u20131379","journal-title":"J Clin Invest"},{"issue":"4","key":"9363_CR16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000152941","volume":"29","author":"L Heyman","year":"2008","unstructured":"Heyman L, Kellouche S, Fernandes J et al (2008) Vitronectin and its receptors partly mediate adhesion of ovarian cancer cells to peritoneal mesothelium in vitro. Tumour Biol 29(4):231\u2013244","journal-title":"Tumour Biol"},{"issue":"7","key":"9363_CR17","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nrc1391","volume":"4","author":"BP Toole","year":"2004","unstructured":"Toole BP (2004) Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 4(7):528\u2013539","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"9363_CR18","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1074\/jbc.R100037200","volume":"277","author":"MI Tammi","year":"2002","unstructured":"Tammi MI, Day AJ, Turley EA (2002) Hyaluronan and homeostasis: a balancing act. J Biol Chem 277(7):4581\u20134584","journal-title":"J Biol Chem"},{"issue":"22","key":"9363_CR19","first-page":"6410","volume":"62","author":"EL Hiltunen","year":"2002","unstructured":"Hiltunen EL, Anttila M, Kultti A et al (2002) Elevated hyaluronan concentration without hyaluronidase activation in malignant epithelial ovarian tumors. Cancer Res 62(22):6410\u20136413","journal-title":"Cancer Res"},{"key":"9363_CR20","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1477-3163-5-2","volume":"5","author":"RK Boregowda","year":"2006","unstructured":"Boregowda RK, Appaiah HN, Siddaiah M et al (2006) Expression of hyaluronan in human tumor progression. J Carcinog 5:2","journal-title":"J Carcinog"},{"issue":"1\u20132","key":"9363_CR21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0304-3835(02)00037-X","volume":"188","author":"M Jojovic","year":"2002","unstructured":"Jojovic M, Delpech B, Prehm P et al (2002) Expression of hyaluronate and hyaluronate synthase in human primary tumours and their metastases in scid mice. Cancer Lett 188(1\u20132):181\u2013189","journal-title":"Cancer Lett"},{"issue":"6","key":"9363_CR22","first-page":"1733","volume":"148","author":"TK Yeo","year":"1996","unstructured":"Yeo TK, Nagy JA, Yeo KT et al (1996) Increased hyaluronan at sites of attachment to mesentery by CD44-positive mouse ovarian and breast tumor cells. Am J Pathol 148(6):1733\u20131740","journal-title":"Am J Pathol"},{"issue":"7","key":"9363_CR23","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1023\/A:1006756518500","volume":"17","author":"JB Catterall","year":"1999","unstructured":"Catterall JB, Jones LM, Turner GA (1999) Membrane protein glycosylation and CD44 content in the adhesion of human ovarian cancer cells to hyaluronan. Clin Exp Metastasis 17(7):583\u2013591","journal-title":"Clin Exp Metastasis"},{"issue":"1","key":"9363_CR24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1023\/A:1026519016213","volume":"18","author":"RC Casey","year":"2000","unstructured":"Casey RC, Skubitz AP (2000) CD44 and beta1 integrins mediate ovarian carcinoma cell migration toward extracellular matrix proteins. Clin Exp Metastasis 18(1):67\u201375","journal-title":"Clin Exp Metastasis"},{"issue":"5","key":"9363_CR25","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1111\/j.1525-1438.2006.00660.x","volume":"16","author":"JM Lancaster","year":"2006","unstructured":"Lancaster JM, Dressman HK, Clarke JP et al (2006) Identification of genes associated with ovarian cancer metastasis using microarray expression analysis. Int J Gynecol Cancer 16(5):1733\u20131745","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"9363_CR26","doi-asserted-by":"crossref","first-page":"245 e1","DOI":"10.1016\/j.ajog.2006.10.874","volume":"196","author":"E Bignotti","year":"2007","unstructured":"Bignotti E, Tassi RA, Calza S et al (2007) Gene expression profile of ovarian serous papillary carcinomas: identification of metastasis-associated genes. Am J Obstet Gynecol 196(3):245 e1\u2013245 e11","journal-title":"Am J Obstet Gynecol"},{"key":"9363_CR27","first-page":"233","volume":"115","author":"RC Bast","year":"2004","unstructured":"Bast RC (2004) Early detection of ovarian cancer: new technologies in pursuit of a disease that is neither common nor rare. Trans Am Clin Climatol Assoc 115:233\u2013248","journal-title":"Trans Am Clin Climatol Assoc"},{"issue":"5","key":"9363_CR28","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0955-0674(02)00375-7","volume":"14","author":"TN Wight","year":"2002","unstructured":"Wight TN (2002) Versican: a versatile extracellular matrix proteoglycan in cell biology. Curr Opin Cell Biol 14(5):617\u2013623","journal-title":"Curr Opin Cell Biol"},{"key":"9363_CR29","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10555-009-9182-y","volume":"28","author":"C Ricciardelli","year":"2009","unstructured":"Ricciardelli C, Sakko AJ, Ween MP et al (2009) The biological role and regulation of versican levels in cancer. Cancer Metastasis Rev 28:233\u2013245","journal-title":"Cancer Metastasis Rev"},{"issue":"4","key":"9363_CR30","first-page":"963","volume":"4","author":"C Ricciardelli","year":"1998","unstructured":"Ricciardelli C, Mayne K, Sykes PJ et al (1998) Elevated levels of versican but not decorin predict disease progression in early-stage prostate cancer. Clin Cancer Res 4(4):963\u2013971","journal-title":"Clin Cancer Res"},{"issue":"4","key":"9363_CR31","first-page":"1054","volume":"8","author":"C Ricciardelli","year":"2002","unstructured":"Ricciardelli C, Brooks JH, Suwiwat S et al (2002) Regulation of stromal versican expression by breast cancer cells and importance to relapse-free survival in patients with node-negative primary breast cancer. Clin Cancer Res 8(4):1054\u20131060","journal-title":"Clin Cancer Res"},{"issue":"11","key":"9363_CR32","first-page":"4190","volume":"9","author":"EE Hanekamp","year":"2003","unstructured":"Hanekamp EE, Gielen SC, Smid-Koopman E et al (2003) Consequences of loss of progesterone receptor expression in development of invasive endometrial cancer. Clin Cancer Res 9(11):4190\u20134199","journal-title":"Clin Cancer Res"},{"issue":"7","key":"9363_CR33","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1158\/1078-0432.CCR-03-0146","volume":"10","author":"S Suwiwat","year":"2004","unstructured":"Suwiwat S, Ricciardelli C, Tammi R et al (2004) Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer. Clin Cancer Res 10(7):2491\u20132498","journal-title":"Clin Cancer Res"},{"issue":"7","key":"9363_CR34","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1136\/jcp.2003.014589","volume":"57","author":"MJ Pukkila","year":"2004","unstructured":"Pukkila MJ, Kosunen AS, Virtaniemi JA et al (2004) Versican expression in pharyngeal squamous cell carcinoma: an immunohistochemical study. J Clin Pathol 57(7):735\u2013739","journal-title":"J Clin Pathol"},{"issue":"1","key":"9363_CR35","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.humpath.2004.10.010","volume":"36","author":"R Pirinen","year":"2005","unstructured":"Pirinen R, Leinonen T, Bohm J et al (2005) Versican in nonsmall cell lung cancer: relation to hyaluronan, clinicopathologic factors, and prognosis. Hum Pathol 36(1):44\u201350","journal-title":"Hum Pathol"},{"issue":"9","key":"9363_CR36","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.ejca.2007.02.007","volume":"43","author":"J Kodama","year":"2007","unstructured":"Kodama J, Hasengaowa, Kusumoto T et al (2007) Versican expression in human cervical cancer. Eur J Cancer 43(9):1460\u20131466","journal-title":"Eur J Cancer"},{"issue":"2","key":"9363_CR37","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/annonc\/mdl370","volume":"18","author":"J Kodama","year":"2007","unstructured":"Kodama J, Hasengaowa, Kusumoto T et al (2007) Prognostic significance of stromal versican expression in human endometrial cancer. Ann Oncol 18(2):269\u2013274","journal-title":"Ann Oncol"},{"issue":"3","key":"9363_CR38","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/jcp.2005.034181","volume":"60","author":"M Pukkila","year":"2007","unstructured":"Pukkila M, Kosunen A, Ropponen K et al (2007) High stromal versican expression predicts unfavourable outcome in oral squamous cell carcinoma. J Clin Pathol 60(3):267\u2013272","journal-title":"J Clin Pathol"},{"issue":"2","key":"9363_CR39","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1023\/A:1022670501667","volume":"20","author":"RC Casey","year":"2003","unstructured":"Casey RC, Oegema TR Jr, Skubitz KM et al (2003) Cell membrane glycosylation mediates the adhesion, migration, and invasion of ovarian carcinoma cells. Clin Exp Metastasis 20(2):143\u2013152","journal-title":"Clin Exp Metastasis"},{"issue":"10","key":"9363_CR40","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1158\/1078-0432.CCR-03-0409","volume":"10","author":"KH Lu","year":"2004","unstructured":"Lu KH, Patterson AP, Wang L et al (2004) Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis. Clin Cancer Res 10(10):3291\u20133300","journal-title":"Clin Cancer Res"},{"issue":"4","key":"9363_CR41","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1161\/01.ATV.19.4.1004","volume":"19","author":"SP Evanko","year":"1999","unstructured":"Evanko SP, Angello JC, Wight TN (1999) Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 19(4):1004\u20131013","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"14","key":"9363_CR42","doi-asserted-by":"crossref","first-page":"10814","DOI":"10.1074\/jbc.M606991200","volume":"282","author":"C Ricciardelli","year":"2007","unstructured":"Ricciardelli C, Russell DL, Ween MP et al (2007) Formation of hyaluronan- and versican-rich pericellular matrix by prostate cancer cells promotes cell motility. J Biol Chem 282(14):10814\u201310825","journal-title":"J Biol Chem"},{"issue":"3","key":"9363_CR43","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/(SICI)1097-0215(19980729)77:3<396::AID-IJC15>3.0.CO;2-6","volume":"77","author":"C Zeng","year":"1998","unstructured":"Zeng C, Toole BP, Kinney SD et al (1998) Inhibition of tumor growth in vivo by hyaluronan oligomers. Int J Cancer 77(3):396\u2013401","journal-title":"Int J Cancer"},{"issue":"41","key":"9363_CR44","doi-asserted-by":"crossref","first-page":"38013","DOI":"10.1074\/jbc.M202404200","volume":"277","author":"S Ghatak","year":"2002","unstructured":"Ghatak S, Misra S, Toole BP (2002) Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase\/Akt cell survival pathway. J Biol Chem 277(41):38013\u201338020","journal-title":"J Biol Chem"},{"issue":"5","key":"9363_CR45","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0002-9440(10)64273-3","volume":"162","author":"JA Ward","year":"2003","unstructured":"Ward JA, Huang L, Guo H et al (2003) Perturbation of hyaluronan interactions inhibits malignant properties of glioma cells. Am J Pathol 162(5):1403\u20131409","journal-title":"Am J Pathol"},{"issue":"14","key":"9363_CR46","doi-asserted-by":"crossref","first-page":"10003","DOI":"10.1016\/S0021-9258(19)50191-0","volume":"267","author":"RG LeBaron","year":"1992","unstructured":"LeBaron RG, Zimmermann DR, Ruoslahti E (1992) Hyaluronate binding properties of versican. J Biol Chem 267(14):10003\u201310010","journal-title":"J Biol Chem"},{"key":"9363_CR47","doi-asserted-by":"crossref","unstructured":"Ween MP, Lokman NA, Hoffmann P et al (2010) Transforming growth factor beta-induced protein secreted by peritoneal cells increases the metastatic potential of ovarian cancer cells. Int J Cancer. doi: 10.1002\/ijc.25494","DOI":"10.1002\/ijc.25494"},{"issue":"Pt 2","key":"9363_CR48","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1242\/jcs.99.2.227","volume":"99","author":"W Knudson","year":"1991","unstructured":"Knudson W, Knudson CB (1991) Assembly of a chondrocyte-like pericellular matrix on non-chondrogenic cells. Role of the cell surface hyaluronan receptors in the assembly of a pericellular matrix. J Cell Sci 99(Pt 2):227\u2013235","journal-title":"J Cell Sci"},{"issue":"2","key":"9363_CR49","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1006\/excr.1996.0320","volume":"228","author":"W Knudson","year":"1996","unstructured":"Knudson W, Aguiar DJ, Hua Q et al (1996) CD44-anchored hyaluronan-rich pericellular matrices: an ultrastructural and biochemical analysis. Exp Cell Res 228(2):216\u2013228","journal-title":"Exp Cell Res"},{"issue":"21","key":"9363_CR50","doi-asserted-by":"crossref","first-page":"17949","DOI":"10.1074\/jbc.M010064200","volume":"276","author":"MA Simpson","year":"2001","unstructured":"Simpson MA, Reiland J, Burger SR et al (2001) Hyaluronan synthase elevation in metastatic prostate carcinoma cells correlates with hyaluronan surface retention, a prerequisite for rapid adhesion to bone marrow endothelial cells. J Biol Chem 276(21):17949\u201317957","journal-title":"J Biol Chem"},{"issue":"16","key":"9363_CR51","doi-asserted-by":"crossref","first-page":"5702","DOI":"10.1158\/0008-5472.CAN-04-0389","volume":"64","author":"JE Draffin","year":"2004","unstructured":"Draffin JE, McFarlane S, Hill A et al (2004) CD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cells. Cancer Res 64(16):5702\u20135711","journal-title":"Cancer Res"},{"key":"9363_CR52","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ygyno.2010.05.029","volume":"119","author":"S Ghosh","year":"2010","unstructured":"Ghosh S, Albitar L, Lebaron R et al (2010) Up-regulation of stromal versican expression in advanced stage serous ovarian cancer. Gynecol Oncol 119:114\u2013120","journal-title":"Gynecol Oncol"},{"issue":"1","key":"9363_CR53","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1593\/neo.91272","volume":"12","author":"YC Tzuman","year":"2010","unstructured":"Tzuman YC, Sapoznik S, Granot D et al (2010) Peritoneal adhesion and angiogenesis in ovarian carcinoma are inversely regulated by hyaluronan: the role of gonadotropins. Neoplasia 12(1):51\u201360","journal-title":"Neoplasia"},{"issue":"44","key":"9363_CR54","doi-asserted-by":"crossref","first-page":"27913","DOI":"10.1074\/jbc.272.44.27913","volume":"272","author":"LY Bourguignon","year":"1997","unstructured":"Bourguignon LY, Zhu H, Chu A et al (1997) Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation. J Biol Chem 272(44):27913\u201327918","journal-title":"J Biol Chem"},{"issue":"10","key":"9363_CR55","doi-asserted-by":"crossref","first-page":"7327","DOI":"10.1074\/jbc.M006498200","volume":"276","author":"LY Bourguignon","year":"2001","unstructured":"Bourguignon LY, Zhu H, Shao L et al (2001) CD44 interaction with c-Src kinase promotes cortactin-mediated cytoskeleton function and hyaluronic acid-dependent ovarian tumor cell migration. J Biol Chem 276(10):7327\u20137336","journal-title":"J Biol Chem"},{"issue":"42","key":"9363_CR56","doi-asserted-by":"crossref","first-page":"39703","DOI":"10.1074\/jbc.M204320200","volume":"277","author":"LY Bourguignon","year":"2002","unstructured":"Bourguignon LY, Singleton PA, Zhu H et al (2002) Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells. J Biol Chem 277(42):39703\u201339712","journal-title":"J Biol Chem"},{"issue":"7","key":"9363_CR57","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1074\/jbc.R100038200","volume":"277","author":"EA Turley","year":"2002","unstructured":"Turley EA, Noble PW, Bourguignon LY (2002) Signaling properties of hyaluronan receptors. J Biol Chem 277(7):4589\u20134592","journal-title":"J Biol Chem"},{"issue":"10","key":"9363_CR58","doi-asserted-by":"crossref","first-page":"8875","DOI":"10.1074\/jbc.M410882200","volume":"280","author":"S Ghatak","year":"2005","unstructured":"Ghatak S, Misra S, Toole BP (2005) Hyaluronan constitutively regulates ErbB2 phosphorylation and signaling complex formation in carcinoma cells. J Biol Chem 280(10):8875\u20138883","journal-title":"J Biol Chem"},{"issue":"4","key":"9363_CR59","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.semcancer.2008.03.007","volume":"18","author":"LY Bourguignon","year":"2008","unstructured":"Bourguignon LY (2008) Hyaluronan-mediated CD44 activation of Rho GTPase signaling and cytoskeleton function promotes tumor progression. Semin Cancer Biol 18(4):251\u2013259","journal-title":"Semin Cancer Biol"},{"issue":"21","key":"9363_CR60","doi-asserted-by":"crossref","first-page":"14335","DOI":"10.1074\/jbc.M703811200","volume":"283","author":"S Misra","year":"2008","unstructured":"Misra S, Obeid LM, Hannun YA et al (2008) Hyaluronan constitutively regulates activation of COX-2-mediated cell survival activity in intestinal epithelial and colon carcinoma cells. J Biol Chem 283(21):14335\u201314344","journal-title":"J Biol Chem"},{"issue":"24","key":"9363_CR61","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.1158\/1078-0432.CCR-09-0479","volume":"15","author":"BP Toole","year":"2009","unstructured":"Toole BP (2009) Hyaluronan-CD44 interactions in cancer: paradoxes and possibilities. Clin Cancer Res 15(24):7462\u20137468","journal-title":"Clin Cancer Res"},{"issue":"12","key":"9363_CR62","doi-asserted-by":"crossref","first-page":"11749","DOI":"10.1074\/jbc.M414495200","volume":"280","author":"ER Bastow","year":"2005","unstructured":"Bastow ER, Lamb KJ, Lewthwaite JC et al (2005) Selective activation of the MEK-ERK pathway is regulated by mechanical stimuli in forming joints and promotes pericellular matrix formation. J Biol Chem 280(12):11749\u201311758","journal-title":"J Biol Chem"},{"issue":"16","key":"9363_CR63","doi-asserted-by":"crossref","first-page":"11011","DOI":"10.1074\/jbc.M510680200","volume":"281","author":"JC Lewthwaite","year":"2006","unstructured":"Lewthwaite JC, Bastow ER, Lamb KJ et al (2006) A specific mechanomodulatory role for p38 MAPK in embryonic joint articular surface cell MEK-ERK pathway regulation. J Biol Chem 281(16):11011\u201311018","journal-title":"J Biol Chem"},{"issue":"8","key":"9363_CR64","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ejcb.2006.05.009","volume":"85","author":"R Stern","year":"2006","unstructured":"Stern R, Asari AA, Sugahara KN (2006) Hyaluronan fragments: an information-rich system. Eur J Cell Biol 85(8):699\u2013715","journal-title":"Eur J Cell Biol"},{"issue":"4","key":"9363_CR65","first-page":"773","volume":"57","author":"VB Lokeshwar","year":"1997","unstructured":"Lokeshwar VB, Obek C, Soloway MS et al (1997) Tumor-associated hyaluronic acid: a new sensitive and specific urine marker for bladder cancer. Cancer Res 57(4):773\u2013777","journal-title":"Cancer Res"},{"issue":"5","key":"9363_CR66","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/glycob\/cwj085","volume":"16","author":"L Alaniz","year":"2006","unstructured":"Alaniz L, Garcia MG, Gallo-Rodriguez C et al (2006) Hyaluronan oligosaccharides induce cell death through PI3-K\/Akt pathway independently of NF-kappaB transcription factor. Glycobiology 16(5):359\u2013367","journal-title":"Glycobiology"},{"issue":"1","key":"9363_CR67","doi-asserted-by":"crossref","first-page":"274","DOI":"10.2353\/ajpath.2007.060828","volume":"171","author":"K Hosono","year":"2007","unstructured":"Hosono K, Nishida Y, Knudson W et al (2007) Hyaluronan oligosaccharides inhibit tumorigenicity of osteosarcoma cell lines MG-63 and LM-8 in vitro and in vivo via perturbation of hyaluronan-rich pericellular matrix of the cells. Am J Pathol 171(1):274\u2013286","journal-title":"Am J Pathol"},{"issue":"12","key":"9363_CR68","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1158\/0008-5472.CAN-09-0143","volume":"69","author":"MG Slomiany","year":"2009","unstructured":"Slomiany MG, Dai L, Bomar PA et al (2009) Abrogating drug resistance in malignant peripheral nerve sheath tumors by disrupting hyaluronan-CD44 interactions with small hyaluronan oligosaccharides. Cancer Res 69(12):4992\u20134998","journal-title":"Cancer Res"},{"issue":"1","key":"9363_CR69","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.canlet.2008.12.029","volume":"278","author":"L Alaniz","year":"2009","unstructured":"Alaniz L, Rizzo M, Malvicini M et al (2009) Low molecular weight hyaluronan inhibits colorectal carcinoma growth by decreasing tumor cell proliferation and stimulating immune response. Cancer Lett 278(1):9\u201316","journal-title":"Cancer Lett"},{"issue":"9","key":"9363_CR70","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/CAD.0b013e32832f9d85","volume":"20","author":"X Cui","year":"2009","unstructured":"Cui X, Zhou S, Xu H et al (2009) Reversal effects of hyaluronan oligosaccharides on adriamycin resistance of K562\/A02 cells. Anticancer Drugs 20(9):800\u2013806","journal-title":"Anticancer Drugs"},{"issue":"5","key":"9363_CR71","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/ijc.23122","volume":"122","author":"RI Cordo Russo","year":"2008","unstructured":"Cordo Russo RI, Garcia MG, Alaniz L et al (2008) Hyaluronan oligosaccharides sensitize lymphoma resistant cell lines to vincristine by modulating P-glycoprotein activity and PI3\u00a0K\/Akt pathway. Int J Cancer 122(5):1012\u20131018","journal-title":"Int J Cancer"},{"issue":"24","key":"9363_CR72","doi-asserted-by":"crossref","first-page":"7593","DOI":"10.1158\/1078-0432.CCR-09-2317","volume":"15","author":"MG Slomiany","year":"2009","unstructured":"Slomiany MG, Dai L, Tolliver LB et al (2009) Inhibition of functional hyaluronan-CD44 interactions in CD133-positive primary human ovarian carcinoma cells by small hyaluronan oligosaccharides. Clin Cancer Res 15(24):7593\u20137601","journal-title":"Clin Cancer Res"},{"issue":"6","key":"9363_CR73","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1593\/neo.07229","volume":"9","author":"E Auzenne","year":"2007","unstructured":"Auzenne E, Ghosh SC, Khodadadian M et al (2007) Hyaluronic acid-paclitaxel: antitumor efficacy against CD44(+) human ovarian carcinoma xenografts. Neoplasia 9(6):479\u2013486","journal-title":"Neoplasia"},{"issue":"11","key":"9363_CR74","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1158\/1078-0432.CCR-07-2019","volume":"14","author":"A Banzato","year":"2008","unstructured":"Banzato A, Bobisse S, Rondina M et al (2008) A paclitaxel-hyaluronan bioconjugate targeting ovarian cancer affords a potent in vivo therapeutic activity. Clin Cancer Res 14(11):3598\u20133606","journal-title":"Clin Cancer Res"},{"issue":"1","key":"9363_CR75","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000180339","volume":"55","author":"P Gibbs","year":"2009","unstructured":"Gibbs P, Brown TJ, Ng R et al (2009) A pilot human evaluation of a formulation of irinotecan and hyaluronic acid in 5-fluorouracil-refractory metastatic colorectal cancer patients. Chemotherapy 55(1):49\u201359","journal-title":"Chemotherapy"},{"key":"9363_CR76","doi-asserted-by":"crossref","unstructured":"Gibbs P, Clingan PR, Ganju V et al (2010) Hyaluronan-Irinotecan improves progression-free survival in 5-fluorouracil refractory patients with metastatic colorectal cancer: a randomized phase II trial. Cancer Chemother Pharmacol. doi: 10.1007\/s00280-010-1303-3","DOI":"10.1007\/s00280-010-1303-3"}],"container-title":["Clinical &amp; Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-010-9363-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10585-010-9363-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-010-9363-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T08:07:17Z","timestamp":1636963637000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10585-010-9363-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,12]]},"references-count":76,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["9363"],"URL":"https:\/\/doi.org\/10.1007\/s10585-010-9363-7","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,12]]}}}